The present invention relates to a compound represented by Formula (I): ##STR00001## and pharmaceutically acceptable salts. Compounds of the present invention inhibit Aurora kinase, making them especially suitable for the treatment of a number of diseases, including solid tumor cancers and hematological cancers.

 
Web www.patentalert.com

< Processes for the synthesis of individual isomers of mono-peg CCI-779

> Polymorphic forms of (S).-tetrahydrofuran-3-yl-3-(3-(3-methoxy-4-(oxazol-5-yl) phenyl) ureido) benzylcarbamate

> Genetically modified human natural killer cell lines
~ 00553